Ann: H1 2023 Preclinical and Clinical Programs Update, page-71

I wonder if we will hear anything of the FTO & ALKBH5 drug discovery program that began in September last year at the strategic update.

I truly hope we are not going to be giving up too much of our FTO opportunity in the near future. Was the word FTO even used once in our updated announcement?

I understand, probably more now than ever, we have a lot going on for our little ASX biotech and we cannot possibly do everything, i just really hope we dont get the short end of the stick if handing over the FTO opportunity as its probably the most exciting and broad opp we have.